Thursday, September 15, 2016

Teva Pharm, Intel to study Huntington disease progression

JERUSALEM, Sept 15 (Reuters) - Teva Pharmaceutical

Industries is collaborating with Intel Corp

to develop a wearable device and machine learning platform for

Huntington disease patients, Teva said on Thursday.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)